In cancer, increased cysteine protease activity, if not balanced by a corresponding increase in cysteine protease inhibitors, leads to the remodeling and degradation of extracellular matrix proteins—an event associated with tumor dissemination, invasion, and metastasis (51). The gene discussed is CTSB; the disease is cancer.